Eisai, Biogen get FDA approval for Alzheimer’s drug
The U.S. Meals and Drug Administration on Friday permitted the Alzheimer's drug lecanemab developed by Eisai Co Ltd and Biogen ...
The U.S. Meals and Drug Administration on Friday permitted the Alzheimer's drug lecanemab developed by Eisai Co Ltd and Biogen ...
A drug developed by Biogen Inc. and Eisai Co. has achieved a primary in Alzheimer’s analysis: In a big, late-stage ...
Copyright © 2022 Asia Today.